Log in

NanoViricides Stock Price, Forecast & Analysis (NYSEAMERICAN:NNVC)

$2.10
-0.05 (-2.33 %)
(As of 11/14/2019 06:06 AM ET)
Today's Range
$2.02
Now: $2.10
$2.24
50-Day Range N/A
52-Week Range
$1.27
Now: $2.10
$13.60
Volume9,700 shs
Average Volume20,795 shs
Market Capitalization$8.07 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as injectable and oral anti-influenza nanoviricide drug for H7N9, Bird Flu H5N1, other Highly Pathogenic Influenzas, Epidemic Influenzas, and Seasonal Influenzas; DengueCide, an anti-dengue nanoviricide which is in pre-clinical development; and HIVCide, an anti-human immunodeficiency virus drug candidate. It is also developing HerpeCide, a skin cream for the treatment of cold sores and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NNVC
Previous SymbolNYSEMKT:NNVC
CUSIPN/A
Phone+1-203-9376137

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees7
Market Cap$8.07 million
Next Earnings Date11/25/2019 (Estimated)
OptionableOptionable

Receive NNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter.


NanoViricides (NYSEAMERICAN:NNVC) Frequently Asked Questions

What is NanoViricides' stock symbol?

NanoViricides trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NNVC."

When did NanoViricides' stock split? How did NanoViricides' stock split work?

Shares of NanoViricides reverse split on Tuesday, September 24th 2019. The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of NanoViricides stock prior to the reverse split would have 5 shares after the split.

How were NanoViricides' earnings last quarter?

NanoViricides Inc (NYSEAMERICAN:NNVC) announced its quarterly earnings results on Tuesday, February, 19th. The company reported ($0.68) EPS for the quarter, missing the Zacks' consensus estimate of ($0.60) by $0.08. View NanoViricides' Earnings History.

When is NanoViricides' next earnings date?

NanoViricides is scheduled to release their next quarterly earnings announcement on Monday, November 25th 2019. View Earnings Estimates for NanoViricides.

Has NanoViricides been receiving favorable news coverage?

Media coverage about NNVC stock has been trending somewhat positive on Thursday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. NanoViricides earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for NanoViricides.

Are investors shorting NanoViricides?

NanoViricides saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 137,100 shares, a decline of 6.5% from the September 30th total of 146,600 shares. Based on an average daily volume of 42,700 shares, the days-to-cover ratio is currently 3.2 days. Approximately 5.0% of the shares of the stock are short sold. View NanoViricides' Current Options Chain.

Who are some of NanoViricides' key competitors?

What other stocks do shareholders of NanoViricides own?

Who are NanoViricides' key executives?

NanoViricides' management team includes the folowing people:
  • Dr. Anil R. Diwan, Chairman, Pres & Sec. (Age 60)
  • Ms. Meeta R. Vyas SB, MBA, Chief Financial Officer (Age 60)
  • Dr. Eugene Seymour, Chief Exec. Officer Emeritus (Age 78)
  • Dr. Randall W. Barton Ph.D., Chief Scientific Officer & Chief Regulatory Officer (Age 72)
  • Dr. Irach B. Taraporewala, Consultant & Director (Age 63)

Who are NanoViricides' major shareholders?

NanoViricides' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Wharton Business Group LLC (0.47%). View Institutional Ownership Trends for NanoViricides.

Which institutional investors are selling NanoViricides stock?

NNVC stock was sold by a variety of institutional investors in the last quarter, including Wharton Business Group LLC. View Insider Buying and Selling for NanoViricides.

How do I buy shares of NanoViricides?

Shares of NNVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NanoViricides' stock price today?

One share of NNVC stock can currently be purchased for approximately $2.10.

How big of a company is NanoViricides?

NanoViricides has a market capitalization of $8.07 million. NanoViricides employs 7 workers across the globe.View Additional Information About NanoViricides.

What is NanoViricides' official website?

The official website for NanoViricides is http://www.nanoviricides.com/.

How can I contact NanoViricides?

NanoViricides' mailing address is 1 Controls Dr, SHELTON, CT 06484-6153, United States. The company can be reached via phone at +1-203-9376137.


MarketBeat Community Rating for NanoViricides (NYSEAMERICAN NNVC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  78 (Vote Underperform)
Total Votes:  138
MarketBeat's community ratings are surveys of what our community members think about NanoViricides and other stocks. Vote "Outperform" if you believe NNVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NNVC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel